Stockreport

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

Biomerica, Inc.  (BMRA) 
NASDAQ:AMEX Investor Relations: biomerica.com/company/investor.asp
PDF New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn’s Disease ($2.5 billion+), and Ulcerative Colitis ( [Read more]